Prelude Therapeutics
PRLD
PRLD
68 hedge funds and large institutions have $235M invested in Prelude Therapeutics in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
37% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 19
46% less capital invested
Capital invested by funds: $438M → $235M (-$202M)
Holders
68
Holding in Top 10
–
Calls
$1.52M
Puts
$20K
Top Buyers
| 1 | +$6.27M | |
| 2 | +$1.07M | |
| 3 | +$422K | |
| 4 |
IA
IndexIQ Advisors
New York
|
+$392K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$392K |
Top Sellers
| 1 | -$3.91M | |
| 2 | -$2.79M | |
| 3 | -$2.06M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.62M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.45M |